Human Papillomavirus (HPV) Clinical Trial
Official title:
Survey Study of the Awareness, Acceptance, and Barriers to Utilization of Human Papillomavirus (HPV) Vaccine Among Young Men Who Have Sex With Men (MSM) and Parents of Boys (Aged 9 to 18 Years)
The objectives of this study are:
1. to determine the degree of understanding and perceived risks for human papillomavirus
(HPV) disease, to examine and assess attitudes for personal use of HPV vaccine and
identify potential barriers to HPV vaccine access and utilization in a population of
young men who have sex with men (MSM) (under 26 years of age)and in parents of boys
aged 9 to 18 years
2. to determine HPV vaccine acceptance and predictors of acceptance in a population of
young MSM and in patients of boys ages 9 to 18 years
3. to develop strategies to overcome potential barriers to vaccination and improve vaccine
access and utilization via development of targeted educational initiatives.
| Status | Recruiting |
| Enrollment | 800 |
| Est. completion date | August 2011 |
| Est. primary completion date | August 2011 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Male |
| Age group | 9 Years to 26 Years |
| Eligibility |
Inclusion Criteria: - MSM group - under age 26 years - Parent group - parent of boy(s) ages 9 to 18 years Exclusion Criteria: - MSM group - previous receipt of HPV vaccine - Parent group - previous receipt of HPV vaccine by male child |
Time Perspective: Prospective
| Country | Name | City | State |
|---|---|---|---|
| United States | Children's Memorial Hospital Uptown Clinic | Chicago | Illinois |
| United States | Erie Family Health Clinic | Chicago | Illinois |
| United States | Howard Brown Health Center | Chicago | Illinois |
| United States | Pediatric Private Practice | Chicago | Illinois |
| United States | Pediatric Private practice | Chicago | Illinois |
| United States | Pediatric Private Practice | Chicago | Illinois |
| United States | Pediatric Private practice | Evanston | Illinois |
| United States | Private pediatric practice | Evanston | Illinois |
| Lead Sponsor | Collaborator |
|---|---|
| Ann & Robert H Lurie Children's Hospital of Chicago |
United States,
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT02540928 -
AMG 319 in HPV Positive and Negative HNSCC
|
Phase 2 | |
| Not yet recruiting |
NCT05727033 -
Extraordinarily Fun Training Project in Compulsory Secondary Education - Sexually Transmitted Infections
|
N/A | |
| Completed |
NCT03111251 -
Multi-component Interventions to Increase HPV Vaccination in a Network of Pediatric Clinics
|
N/A | |
| Withdrawn |
NCT04849377 -
RBD-HPV: Risk-Based De-Intensification for HPV+ HNSCC
|
Phase 2 | |
| Completed |
NCT02873741 -
New Strategies to Assess Anal Cancer Risk In Women
|
||
| Completed |
NCT01188850 -
Fourth Dose of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + EP in Adult Females Previously Vaccinated With Three Doses of VGX-3100
|
Phase 1 | |
| Completed |
NCT02524223 -
Prevalence of HPV Transmission During Medically Assisted Procreation Procedures
|
N/A | |
| Completed |
NCT03180684 -
Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)
|
Phase 2 | |
| Recruiting |
NCT05539638 -
The Role of Circulating Tumour DNA in Head and Neck Cancer
|